Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial

被引：0
|
作者：
Job A. J. Verdonschot
João Pedro Ferreira
Pierpaolo Pellicori
Hans-Peter Brunner-La Rocca
Andrew L. Clark
Franco Cosmi
Joe Cuthbert
Nicolas Girerd
Beatrice Mariottoni
Johannes Petutschnigg
Patrick Rossignol
John G. F. Cleland
Faiez Zannad
Stephane R. B. Heymans
机构：
[1] Maastricht University Medical Center,Department of Clinical Genetics
[2] Centre d’Investigations Cliniques Plurithématique 1433,Robertson Centre for Biostatistics, Institute of Health and Wellbeing
[3] Université de Lorraine,Department of Cardiology
[4] Institut National de la Santé et de la Recherche Médicale 1116,Department of Cardiology
[5] Centre Hospitalier Régional Universitaire de Nancy,Department of Cardiology
[6] French Clinical Research Infrastructure Network,Department of Internal Medicine and Cardiology
[7] Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists,undefined
[8] University of Glasgow,undefined
[9] Glasgow Royal Infirmary,undefined
[10] Maastricht University Medical Center (MUMC+),undefined
[11] University of Hull,undefined
[12] Castle Hill Hospital,undefined
[13] Cortona Hospital,undefined
[14] Campus Virchow Klinikum,undefined
[15] Charite´ University Medicine Berlin,undefined
[16] Berlin Institute of Health (BIH),undefined
[17] and German Centre for Cardiovascular research (DZHK),undefined
[18] Partner Site Berlin,undefined
来源：
Cardiovascular Diabetology | / 20卷
关键词：
Diabetes; Biomarker; Heart failure; Spironolactone; Fibrosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial
    Verdonschot, Job A. J.
    Ferreira, Joao Pedro
    Pellicori, Pierpaolo
    Brunner-La Rocca, Hans-Peter
    Clark, Andrew L.
    Cosmi, Franco
    Cuthbert, Joe
    Girerd, Nicolas
    Mariottoni, Beatrice
    Petutschnigg, Johannes
    Rossignol, Patrick
    Cleland, John G. F.
    Zannad, Faiez
    Heymans, Stephane R. B.
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [2] The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE Trial
    Verdonschot, Job A. J.
    Ferreira, JoAo Pedro
    Pizard, Anne
    Pellicori, Pierpaolo
    La Rocca, Hans-Peter Brunner
    Clark, Andrew L.
    Cosmi, Franco
    Cuthbert, Joe
    Girerd, Nicolas
    Waring, Olivia J.
    Henkens, Michiel H. T. M.
    Mariottoni, Beatrice
    Petutschnigg, Johannes
    Rossignol, Patrick
    Hazebroek, Mark R.
    Cleland, John G. F.
    Zannad, Faiez
    Heymans, Stephane R. B.
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : 778 - 786
  • [3] The prevalence and clinical associations of ultrasound measures of congestion in patients at risk of developing heart failure: insights from the HOMAGE trial.
    Cuthbert, Joseph
    Pellicori, P.
    Flockton, R.
    Kallvikbacka-Bennett, A.
    Khan, J.
    Cleland, J. G.
    Clark, A. L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 52 - 52
  • [4] Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial
    Santos-Ferreira, Diogo
    Diaz, Silvia O.
    Ferreira, Joao Pedro
    Girerd, Nicolas
    Pellicori, Pierpaolo
    Mariottoni, Beatrice
    Cosmi, Franco
    Hazebroek, Mark
    Verdonschot, Job A. J.
    Cuthbert, Joe
    Petutschnigg, Johannes
    Heymans, Stephane
    Staessen, Jan A.
    Pieske, Burkert
    Edelmann, Frank
    Clark, Andrew L.
    Rossignol, Patrick
    Fontes-Carvalho, Ricardo
    Cleland, John G. F.
    Zannad, Faiez
    ESC HEART FAILURE, 2024, 11 (01): : 209 - 218
  • [5] Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial
    Ferreira, Joao Pedro
    Collier, Timothy
    Clark, Andrew L.
    Mamas, Mamas A.
    Brunner-La Rocca, Hans-Peter
    Heymans, Stephane
    Gonzalez, Arantxa
    Ahmed, Fozia Z.
    Petutschnigg, Johannes
    Mujaj, Blerim
    Cuthbert, Joe
    Rouet, Philippe
    Pellicori, Pierpaolo
    Mariottoni, Beatrice
    Cosmi, Franco
    Edelmann, Frank
    Thijs, Lutgarde
    Staessen, Jan A.
    Hazebroek, Mark
    Verdonschot, Job
    Rossignol, Patrick
    Girerd, Nicolas
    Cleland, John G.
    Zannad, Faiez
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (02) : 149 - 156
  • [6] Paying Homage to the Power of Proteomics: Insights Into Obesity and Heart Failure From the HOMAGE Trial
    Harrington, Josephine
    Tseliou, Eleni
    Shah, Svati
    Shah, Kevin S.
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : 787 - 788
  • [7] Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure The HOMAGE Study
    Ferreira, Joao Pedro
    Verdonschot, Job
    Collier, Timothy
    Wang, Ping
    Pizard, Anne
    Bar, Christian
    Bjorkman, Jens
    Boccanelli, Alessandro
    Butler, Javed
    Clark, Andrew
    Cleland, John G.
    Delles, Christian
    Diez, Javier
    Girerd, Nicolas
    Gonzalez, Arantxa
    Hazebroek, Mark
    Huby, Anne-Cecile
    Jukema, Wouter
    Latini, Roberto
    Leenders, Joost
    Levy, Daniel
    Mebazaa, Alexandre
    Mischak, Harald
    Pinet, Florence
    Rossignol, Patrick
    Sattar, Naveed
    Sever, Peter
    Staessen, Jan A.
    Thum, Thomas
    Vodovar, Nicolas
    Zhang, Zhen-Yu
    Heymans, Stephane
    Zannad, Faiez
    CIRCULATION-HEART FAILURE, 2019, 12 (05)
  • [8] Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial
    Ferreira, Joao Pedro
    Cleland, John G. F.
    Girerd, Nicolas
    Pellicori, Pierpaolo
    Hazebroek, Mark R.
    Verdonschot, Job
    Collier, Timothy J.
    Petutschnigg, Johannes
    Clark, Andrew L.
    Staessen, Jan A.
    Heymans, Stephane
    Zannad, Faiez
    Rossignol, Patrick
    CLINICAL RESEARCH IN CARDIOLOGY, 2023, 112 (02) : 330 - 332
  • [9] Effects of spironolactone on exercise blood pressure in patients at increased risk of developing heart failure: report from the HOMAGE trial
    Wei, Fang-Fei
    Pellicori, Pierpaolo
    Ferreira, Joao Pedro
    Gonzalez, Arantxa
    Mariottoni, Beatrice
    An, De-Wei
    Verdonschot, Job A. J.
    Liu, Chen
    Ahmed, Fozia Z.
    Petutschnigg, Johannes
    Rossignol, Patrick
    Heymans, Stephane
    Cuthbert, Joe
    Girerd, Nicolas
    Clark, Andrew L.
    Li, Yan
    Nawrot, Tim S.
    Diez, Javier
    Zannad, Faiez
    Cleland, John G. F.
    Staessen, Jan A.
    HYPERTENSION RESEARCH, 2024, 47 (11) : 3225 - 3236
  • [10] Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial
    João Pedro Ferreira
    John G. F. Cleland
    Nicolas Girerd
    Pierpaolo Pellicori
    Mark R. Hazebroek
    Job Verdonschot
    Timothy J. Collier
    Johannes Petutschnigg
    Andrew L. Clark
    Jan A. Staessen
    Stephane Heymans
    Faiez Zannad
    Patrick Rossignol
    Clinical Research in Cardiology, 2023, 112 : 330 - 332
12345